American Well a Aktie
WKN DE: A2QCFY / ISIN: US03044L1052
06.08.2025 03:46:32
|
American Well (AMWL) Q2 Revenue Up 13%
American Well (NYSE:AMWL), a major telehealth solutions provider, reported second-quarter 2025 results on August 5, 2025. The standout detail: GAAP revenue of $70.9 million in Q2 2025 outpaced analyst expectations by more than $7.4 million, alongside a record gross margin of 56.1% in Q2 2025. Adjusted EBITDA loss improved sharply to $(4.7 million) in Q2 2025 The quarter saw software subscriptions become the dominant revenue driver, but management revised full-year revenue guidance to $245–$250 million for 2025 as the planned divestiture of Amwell Psychiatric Care trimmed short-term sales. Overall, the period showed robust progress on profitability and strategic execution. Source: Analyst estimates provided by FactSet. Management expectations based on management's guidance, as provided in Q1 2025 earnings report. American Well provides a digital health platform designed for virtual care delivery. Its core offering connects patients, providers, and healthcare systems for a range of clinical and behavioral health services. The mainstay product, called Converge, is a software platform that supports telehealth visits, patient scheduling, and care coordination across healthcare networks.Continue readingWeiter zum vollständigen Artikel bei MotleyFool

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu American Well Corporation Registered Shs -A-mehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu American Well Corporation Registered Shs -A-mehr Analysen
Aktien in diesem Artikel
Q2 Holdings Inc | 60,50 | -2,42% |
|